BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 22622948)

  • 1. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.
    Fountoulakis KN; Kasper S; Andreassen O; Blier P; Okasha A; Severus E; Versiani M; Tandon R; Möller HJ; Vieta E
    Eur Arch Psychiatry Clin Neurosci; 2012 Jun; 262 Suppl 1():1-48. PubMed ID: 22622948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.
    Fountoulakis KN; Vieta E
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):999-1029. PubMed ID: 18752718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating mixed mania/hypomania: a review and synthesis of the evidence.
    Takeshima M
    CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polytherapy in bipolar disorder.
    Lin D; Mok H; Yatham LN
    CNS Drugs; 2006; 20(1):29-42. PubMed ID: 16396522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
    Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
    Verdolini N; Hidalgo-Mazzei D; Murru A; Pacchiarotti I; Samalin L; Young AH; Vieta E; Carvalho AF
    Acta Psychiatr Scand; 2018 Sep; 138(3):196-222. PubMed ID: 29756288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
    Calvert NW; Burch SP; Fu AZ; Reeves P; Thompson TR
    J Manag Care Pharm; 2006 May; 12(4):322-30. PubMed ID: 16792438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latest therapies for bipolar disorder. Looking beyond lithium.
    Goldberg JF; Citrome L
    Postgrad Med; 2005 Feb; 117(2):25-6, 29-32, 35-6. PubMed ID: 15745123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of bipolar depression: an update.
    Fountoulakis KN; Grunze H; Panagiotidis P; Kaprinis G
    J Affect Disord; 2008 Jul; 109(1-2):21-34. PubMed ID: 18037498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment guidelines for bipolar disorder: a critical review.
    Fountoulakis KN; Vieta E; Sanchez-Moreno J; Kaprinis SG; Goikolea JM; Kaprinis GS
    J Affect Disord; 2005 May; 86(1):1-10. PubMed ID: 15820265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.
    Rosa AR; Fountoulakis K; Siamouli M; Gonda X; Vieta E
    CNS Neurosci Ther; 2011 Jun; 17(3):167-77. PubMed ID: 20015083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics for bipolar disorder.
    Yatham LN
    Psychiatr Clin North Am; 2005 Jun; 28(2):325-47. PubMed ID: 15826735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
    Woodward TC; Tafesse E; Quon P; Lazarus A
    Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.